Figure 2.Kaplan-Meier survival curves comparing gastric cancer-specific survival between non-diabetic and diabetic patients (p = 0.29) and by antihyperglycemic medication user group (p=0.013).
Figure 2 — A cohort study of antihyperglycemic medication exposure and survival in patients with gastric cancer | Aging
